In this context, an ePHAS study has reported that the presence of a specific haplotype of eNOS-786 (rs2070744) and eNOS VNTR polymorphisms may identify a subset of HCC patients who are more resistant to sorafenib [43]. The gene discussed is NOS3; the disease is hepatocellular carcinoma.